Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles.
Transmembrane topography of nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles.
复制标题
烟碱乙酰胆碱受体的跨膜形貌:免疫化学测试与基于疏水性特征的理论预测相矛盾。
DOI:
10.1021/bi00357a052
复制
发表时间:
1986
期刊:
影响因子:
2.9
通讯作者:
Lindstrom,J
中科院分区:
文献类型:
--
作者:
Ratnam,M;Nguyen,DL;Rivier,J;Sargent,PB;Lindstrom,J
Revised Manuscript Received December 10, 1985 abstract: In our preceding paper [Ratnam, M., Sargent, P. B., Sarin, V., Fox, J. L., Le Nguyen, D., Rivier, J., Criado, M., & Lindstrom, J.(1986) Biochemistry (preceding paper in this issue)], we presented results from peptide mapping studies of purified subunits of the Torpedo acetylcholine receptor which suggested that the sequence/3429-441 is on the cytoplasmic surface of the receptor. Since thisfinding contradicts earlier theoretical models of the transmembrane structure of the receptor, which placed this sequence of the 0 subunit on the extracellular surface, we investigated the location of the corresponding sequence (389-408) and adjacent sequences of the a subunit by a more direct approach. We synthesizedpeptides including the sequences «330-346, a349-364,«360-378, a379-385, and «389-408 and shorter parts of these peptides. These peptides corresponded to a highly immunogenic region, and by using 125I-labeled peptides as antigens, we were able to detect in our library of monoclonal antibodies to a subunits between two and six which bound specifically to each of these peptides, except a389-408. We obtained antibodies specific for a389-408 both from antisera against the denatured a subunit and from antisera made against the peptide. These antibodies were specific to a389-396. In binding assays, antibodies specific for all of these five peptides bound to receptor-rich membrane vesicles only after permeabilization of the vesicles to permit access of the antibodies to the cytoplasmic surface of the receptors, suggesting that the receptor sequences which bound these antibodies were located on the intracellular side of the membrane. Electron microscopy using colloidal gold to visualize the bound antibodies was used to conclusivelydemonstrate that all of these sequences are exposed on the cytoplasmic surface of the receptor. These results, along with our previous demonstration that the C-terminal 10 amino acids of each subunit are exposed on the cytoplasmic surface, show that the hydrophobic domain M4 (a409-426), previously predicted from hydropathy profiles to be transmembranous, does not, in fact, cross the membrane. Further, these results show that the putative amphipathic trans-membrane domain M5 (a364-399) also does not cross the membrane. Our results thus indicate that the transmembrane topology of a membrane protein cannot be deduced strictly from the hydropathyprofile of its primary amino acid sequence. We present a model for the transmembrane orientation of receptor subunit polypeptide chains which is consistent with current data..^^. ntibodies against synthetic peptides are reliable probes for studying protein structure as they have frequently been found to cross-react specifically with the native proteins containing these sequences (Niman et al., 1983). Antibodies against synthetic peptides corresponding to various parts of the primary sequence of the nicotinic acetylcholine receptor have been used to visualize the binding domains of these antibodiesin re-ceptor-rich membranes (Lindstrom et al., 1984; Ratnam & Lindstrom, 1984; Criado et al., 1985a, b; Young et al., 1985; La Rochelle et al., 1985). Therationale for choosingthe synthetic peptides in these studies was based on plausible theoretical models of the receptor structurededuced from the hydrophobicity profiles of the primary sequences of the sub-units of the receptor (Noda et al., 1983; Claudio et al., 1983; fThis work was supported by grants to JL from the National Institutes of Health (NS11323), the Muscular Dystrophy Association, the Alexander Onassis PublicBenefit Foundation, and the Los Angeles …